Skip to main content

Dr. James H. Lee, MD

Ophthalmology (Ophthalmology Physician)

  • Medicare participating

At a glance

Medical school
Illinois Medical College (1994)
Years since graduation
32
In the NPI registry since
2006
Medicare patients seen, 2024
1,016

Licensed in Colorado since 2006, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1994Medical school: Illinois Medical College
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Ophthalmology Physician primary
    CO license 45206 (first issued 2006; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Ophthalmology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,016
Services billed
4,051
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient complete exam of visual system874659
Established patient office or other outpatient visit, 30-39 minutes598275
Imaging of retina593363
Established patient office or other outpatient visit, 20-29 minutes440259
Exam of visual field with extended testing407333
Imaging of optic nerve339290
Measurement of corneal curvature and depth of eye200105
Photography of the retina191184
Removal of cataract with insertion of prosthetic lens15488
New patient complete exam of visual system138138

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 8 companies reported 36 payments worth $1,195 in total to this clinician.

By company
Alcon Vision LLC$635
Rxsight Inc$193
Glaukos Corporation$170
Vantage Technology LLC$53.56
AbbVie Inc.$52.32
Oyster Point Pharma, Inc.$47.24
Bausch & Lomb Americas Inc.$22.79
Tarsus Pharmaceuticals, Inc.$21.86
By type
Food and Beverage$1,195

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Colorado →

Industry-funded research

Named as a principal investigator on 6 industry-funded studies in 2025, from 2 companies. The companies reported $106,508 in research payments for these studies, mostly to the institutions running them.

  • A prospective, multicenter study of the glaukos istent infinite trabecular micro-bypass system model IS3 in subjects with mild to moderate primary open-angle glaucoma
    Glaukos Corporation
  • Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
    AbbVie Inc. · Completed · NCT03891446
  • A Phase 3, Multi-center, Randomized, Double-masked, Placebo/Sham-controlled Study to Evaluate the Safety and Efficacy of Oxygen Enriched, Non-invasive Epithelium-on Corneal Collagen Cross-linking in Eyes with Keratoconus
    Glaukos Corporation
  • Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
    AbbVie Inc.
  • A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
    AbbVie Inc.
  • Follow-up of Eyes that Received Epithelium-on Corneal Collagen Cross-Linking Treatment in Study GLK-202-13
    Glaukos Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Ophthalmology clinicians in Colorado Springs

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 14, 2010), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1396772372. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.